Weekends-off efavirenz-based antiretroviral therapy in HIV-infected children, adolescents, and young adults (BREATHER): a randomised, open-label, non-inferiority, phase 2/3 trial. (2016)

First Author: BREATHER (PENTA 16) Trial Group
Attributed to:  Paediatric and adolescent infections funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2352-3018(16)30054-6

PubMed Identifier: 27562743

Publication URI: http://europepmc.org/abstract/MED/27562743

Type: Journal Article/Review

Volume: 3

Parent Publication: The lancet. HIV

Issue: 9

ISSN: 2352-3018